Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 13, No 3 (2020) Parameters for evaluating the main indicators of coloproctological care in the adult population in the subjects of the far Eastern Federal District in 2016–2018 Abstract  similar documents
A. V. Veselov, V. V. Omelyanosvkiy, Yu. A. Shelygin, A. V. Vitko, V. N. Kashnikov, N. V. Tashkinov, T. V. Shkurko, A. I. Moskalev, A. A. Serbina
"... statistical observation “The Report of the Chief Coloproctologist of the Russian Federal District” in 2016 ..."
 
Vol 10, No 1 (2017) THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OUTPATIENTS IN THE FAR EAST FEDERAL DISTRICT Abstract  similar documents
V. A. Nevzorova, M. V. Mokshina, T. A. Brodskaya, D. A. Vasil’chenkov, D. V. Blinov, T. I. Ushakova
"... , the population of patients with NAFLD in the Far East Federal District (FEFD) was studied as part ..."
 
Vol 11, No 2 (2018) Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations Abstract  similar documents
M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov
"... ) in 2018 provides for the reimbursement for hospital stay expenses by the compulsory medical insurance fund ..."
 
Vol 12, No 3 (2019) Regulatory and legal status of clinical guidelines and their role in the quality control of medical care in countries of the European Union, North America and Asia Abstract  similar documents
V. K. Fedyaeva , U. N. Dmitrieva , N. I. Juravleva , N. I. Juravlev , M. Yu. Kovaleva , A. S. Korobkina , O. A. Sukhorukikh , A. A. Pashkina
"... Introduction. In 2016-2018, the approaches to the development and use of clinical guidelines ..."
 
Vol 7, No 2 (2014) ANALYSIS OF DRUG PRODUCTS ASSORTMENT ACQUIRABLE BY HEALTHCARE ORGANIZATIONS FOR MEDICAL TREATMENT IN HOSPITAL SETTINGS WAS CONDUCTED Abstract  similar documents
M. G. Malaev
 
Vol 12, No 4 (2019) Clinical and economic analysis of drug costs in a general hospital in 2014-2018 Abstract  similar documents
A. T. Burbello, A. S. Fedorenko, E. L. Latariya, M. V. Pokladova, K. A. Zagorodnikova
"... with a simultaneous analysis of case histories. Results. The analysis of drug purchases in 2014-2018 and the obtained ..."
 
Vol 9, No 1 (2016) MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 Abstract  similar documents
A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum
"... included into the reimbursement lists acting from 2016. The model of expert body decision had an error 7 ..."
 
Vol 12, No 1 (2019) Prevalence survey of musculoskeletal and connective tissue disorders in the Russian Federation Abstract  similar documents
T. A. Oleynikova, D. N. Pozhidaeva, A. Yu. Oreshko
"... situation and predict the prevalence of these diseases in Russia for 2018-2019. Materials and methods: we ..."
 
Vol 8, No 3 (2015) GOVERNMENTAL FUNDING OF BIOMEDICAL RESEARCH IN THE UNITED STATES OF AMERICA, GREAT BRITAIN AND GERMANY Abstract  similar documents
G. R. Khachatrtyan, O. Yu. Rebrova, V. V. Omelyanovskiy
 
Vol 8, No 4 (2015) PLANNING OF EXTENT AND FINANCIAL EXPENSES FOR DELIVERY OF HEALTH CARE IN HOSPITALS AT THE FEDERAL AND REGIONAL LEVELS Abstract  similar documents
M. V. Sura
"... at the federal and regional levels within the frameworks of PSG and TPSG in 2015. Materials and methods ..."
 
Vol 11, No 2 (2018) Implementation of the Federal Law «On Protection of Consumer Rights» in the provision of paid medical services: recommendations on signing the contract Abstract  similar documents
M. A. Amkhadova, E. V. Batler, D. G. Ilyuhin, I. A. Petrova
"... This article addresses the implementation of Federal Law no. 2300-1 dated February 7, 1992 ..."
 
Vol 9, No 2 (2016) EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NOVOSIBIRSK (SIBERIAN FEDERAL DISTRICT): REGIONAL DATA OF OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2 Abstract  similar documents
V. V. Tsukanov, A. S. Yurkina, T. A. Ushakova, D. V. Blinov
"... current prevalence of NAFLD in Novosibirsk (Siberian Federal district) and to compare with DIREG 2 results ..."
 
Vol 12, No 3 (2019) Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support Abstract  similar documents
E. V. Eliseeva , E. S. Maneeva , R. K. Goncharova , A. V. Kropotov
"... to Certain Categories of Citizens in the Russian Federation” in two regions of the Far Eastern Federal ..."
 
Vol 11, No 4 (2018) Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions Abstract  similar documents
G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina
"... (LPD) in the Russian Federation in 2016- 2017. Materials and methods. Treating physicians in 75 regions ..."
 
Vol 12, No 4 (2019) The health technology assessment system in Australia Abstract  similar documents
V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan
"... In Australia, the federal government is in charge of providing the health care to patients ..."
 
Vol 6, No 3 (2013) THE MONITORING RESEARCHES OF HIV/AIDS ON THE BASIS OF THE SITUATION ANALYSIS Abstract  similar documents
N. B. Dremova, I. V. Alekseev
"... of the Central Federal District of Russia for the period 2009-2012. With the application of complex of economic ..."
 
Vol 12, No 3 (2019) Diagnosis-related groups and payments for the treatment of malignant neoplasms in the model of 2019 Abstract  similar documents
D. V. Fedyaev , V. V. Omelyanovskiy , M. L. Lazareva , Yu. V. Seryapina, Yu. A. Ledovskikh
"... describes the functioning of the DRG model in 2018 and the payment for cancer care and also provides ..."
 
Vol 13, No 2 (2020) Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 Abstract  similar documents
V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan
"... No. 871 from August 28, 2014 (with amendments from November 20, 2018). The authors analyzed the historical ..."
 
Vol 8, No 3 (2015) ORGANIZATION AND ANALYSIS OF THE COMMISSION'S WORK ON THE SELECTION AND REFERRAL OF PATIENTS IN A MEDICAL INSTITUTION FOR TREATMENT USING ASSISTED REPRODUCTIVE TECHNOLOGIES ON THE TERRITORY OF THE CHELYABINSK REGION Abstract  similar documents
M. G. Moskvicheva, V. V. Saharova, Yu. A. Semenov, E. V. Orehova
"... at the expense of means of regional and federal budgets. In the work the Commission considers indications ..."
 
Vol 8, No 1 (2015) PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION Abstract  similar documents
M. V. Avxentyeva, N. A. Avxentyev, M. Yu. Frolov, E. V. Derkach
"... impact for everolimus inclusion into 7 expensive diseases program (7EDP). 7 EDP is the special federal ..."
 
Vol 8, No 1 (2015) DEFINING THE MAIN TYPES OF RESEARCH AND DEVELOPMENT FOR PURPOSES OF SHAPING STATE R&D POLICY IN RUSSIA AND IN OECD COUNTRIES Abstract  similar documents
O. V. Bogacheva, O. A. Feoktistova
"... . The paper proposes and discusses the required amendments to the latest revision of the Federal Law ..."
 
Vol 10, No 2 (2017) PHARMACOECONOMIC EVALUATION OF POMALIDOMIDE (IMNOVID) FOR THE TREATMENT OF RECURRENT AND REFRACTORY MULTIPLE MYELOMA Abstract  similar documents
M. Yu. Frolov, O. V. Shatalova
"... procurement. If introduced this program can save the Federal budget up to 232 785 963 rubles. Conclusion ..."
 
Vol 12, No 4 (2019) Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation Abstract  similar documents
A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev
"... of 2018. We calculated the difference between the drug costs in the baseline scenario and the costs ..."
 
Vol 8, No 3 (2015) LEGAL REGULATION OF STATE MANAGEMENT OF MEDICAL SCIENCE Abstract  similar documents
L. S. Melnikova, O. Yu. Rebrova, V. V. Omelyanovskiy
"... activities is the Federal Law of 23 August 1996 N 127-FZ "On Science and State Technical Policy". The basic ..."
 
Vol 12, No 3 (2019) Overview of the existing opportunities and limitations of the state guarantees program for provision of free medical care to citizens Abstract  similar documents
D. V. Fedyaev , R. V. Gostishchev , V. A. Lemeshko , O. I. Ivakhnenko 
"... , the federal and regional regulatory legal acts were analyzed, in terms of the methodology for the formation ..."
 
Vol 10, No 1 (2017) PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMPACT ANALYSIS Abstract  similar documents
A. S. Kolbin, I. A. Vilum, М. A. Proskurin, Yu. E. Balykina
"... . Recommendations to carry out a budget impact analysis in theRussian Federation (2016) were used. Results ..."
 
Vol 5, No 1 (2012) DYNAMICS OF PREFERENTIAL MAINTENANCE OF CITIZENS WITH ANTIHYPERTENSIVE DRUGS AT THE EXPENSE OF THE REGIONAL BUDGET Abstract  similar documents
I. I. Lavrentyeva, A. I. Khokhlov, I. N. Kagramanyan, T. A. Gorokhova
"... of the population of the free medicinal help according to Federal Law №178-ФЗ from 7/17/1999 the increasing loading ..."
 
Vol 6, No 3 (2013) THE ANALYSIS OF THE MARKET OF PHARMACEUTICALS FOR DYSMENORRHEA TREATMENT Abstract  similar documents
N. Yu. Cherkasova, A. V. Fomina, O. V. Filippova
"...  there is a broad assortment, just a few medicines lead in the sales market and have a stabile demand. Federal ..."
 
Vol 9, No 2 (2016) PHARMACOECONOMIC ANALYSIS OF THE THERAPY OF СHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS IN HOSPITAL CONDITIONS Abstract  similar documents
E. E. Vidyakina, S. V. Malchikova
"... of exacerbations of COPD, the appropriate Federal clinical guidelines, simultaneously, there is an active ..."
 
Vol 12, No 2 (2019) New framework for the development of clinical guidelines in Russia Abstract  similar documents
D. V. Blinov, E. S. Akarachkova, A. S. Orlova, E. V. Kryukov, D. I. Korabelnikov
"... confirming the concept and status of the CG, in particular, the Federal Law № 323-ФЗ “On the principles ..."
 
Vol 9, No 3 (2016) DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY Abstract  similar documents
M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov
"... from federal and regional budgets in 2013 in the regions of the Russian Federation for patients ..."
 
Vol 11, No 4 (2018) Direct medical costs of using enzalutamide or abiraterone in chemotherapy-naïve patients with metastatic castration resistant prostate cancer Abstract  similar documents
N. A. Avxentyev, A. S. Makarov, M. Yu. Frolov
"... or abiraterone are almost equal on the federal level, but the differences in the costs between these two ..."
 
Vol 12, No 1 (2019) The use of the level of evidence and grade of recommendations scales in developing clinical guidelines in the Russian Federation Abstract  similar documents
N. I. Zhuravleva, L. C. Shubina, O. A. Sukhorukikh
"... .09.2017; the materials were stored in the Federal Electronic Medical Library. The study included several stages: analysis ..."
 
Vol 11, No 3 (2018) Ocrelizumab – a monoclonal antibody – in the treatment of adult patients with multiple sclerosis: a systematic review Abstract  similar documents
D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, K. I. Polyakova, A. G. Fisun, K. A. Kokushkin
"... was conducted in 2018 by using the embase, PubMed, Cochrane and eLibrary.ru databases and the «ocrelizumab ..."
 
Vol 12, No 2 (2019) Concerning the “repression” of ω -3 polyunsaturated fatty acids by adepts of evidence-based medicine Abstract  similar documents
I. Yu. Torshin, O. A. Gromova, Zh. D. Kobalava
"... in 2018 in the Cochrane Database Syst Rev journal under the code number “CD00317F. The authors claim ..."
 
Vol 12, No 2 (2019) Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available Abstract  similar documents
F. V. Gorkavenko, A. V. Nikitina, E. S. Saibel’, M. V. Avksent’eva, M. V. Sura, D. V. Fedyaev
"... in 2010-2018. Results. With an overall downward trend in prices, differences between individual drugs ..."
 
Vol 13, No 3 (2020) The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups Abstract  similar documents
E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan
"... the necessity in the differentiated payment for the therapy with GEBD and SI. However, at the federal level ..."
 
Vol 9, No 1 (2016) COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA Abstract  similar documents
G. R. Khachatryan, D. V. Fedyaev, M. V. Avxentyeva, V. S. Dombrovskiy
"... , both drugs included into 2016 Essential and Vital Drugs List: 2,5 million rub. and 923 thousand rub ..."
 
Vol 10, No 1 (2017) BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS Abstract  similar documents
E. A. Pyadushkina
"... , and the regulations of financial expenses in the Russian Federation Health system in 2016, were used in this analysis ..."
 
Vol 11, No 3 (2018) What is the role of antineoplastic drug safety in reimbursement decision making? Abstract  similar documents
A. S. Kolbin, A. A. Kurylev
"... between 2014 and 2016. The year of submission, the international drug name, the total safety score ..."
 
Online First Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm Abstract  similar documents
M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov
"... using the cost of illness analysis in a model developed in Microsoft Excel 2016 (Microsoft, USA ..."
 
Vol 7, No 3 (2014) PROBLEMS OF OUTCOMES CHOICE FOR THE ASSESSMENT OF REHABILITATION PROGRAMS EFFICIENCY IN PATIENTS AFTER STROKE AND CRANIOCEREBRAL INJURY Abstract  similar documents
V. S. Dombrovskiy, V. V. Omelyanovskiy
"... course. A notion of Disability conferred by the Federal State Institutions of Disability Evaluation ..."
 
Vol 10, No 3 (2017) Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis Abstract  similar documents
E. V. Biryukova, V. I. Ignat’eva
"... the federal healthcare budget. Materials and Methods. Based on the results of the DURABLE clinical trial, we ..."
 
Vol 9, No 4 (2016) THE COSTS OF REGIONAL ANESTHESIA WITH THE USE OF LEVOBUPIVACAINE, RACEMIC BUPIVACAINE AND ROPIVACAINE Abstract  similar documents
G. E. Ulrikh, A. V. Rudakova
"... into account the consumption of local anesthetics in 2016 (according to IMS Health), the replacement ..."
 
Vol 11, No 1 (2018) Antimicrobial therapy of community-acquired pneumonia in a hospital setting (clinical and economic aspects) Abstract  similar documents
O. V. Zhukova, O. V. Ruina, M. V. Khazov, S. V. Romanov
"... patients with CAP hospitalized in FBU PMLC FMBA in the city of Nizhny Novgorod during 2016 were studied ..."
 
Vol 12, No 3 (2019) Pharmacoepidemiological analysis of antimicrobial therapy for burn injury in the hospital settings Abstract  similar documents
O. V. Zhukova, E. S. Nekaeva, E. S. Khoroshavina, E. A. Kozlova, Yu. A. Dudukina, I. Yu. Arefyev
"... injuries hospitalized in the Volga University Hospital (Nizhny Novgorod) in 2018. DDD (Defined Daily Dose ..."
 
Vol 7, No 3 (2014) ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION Abstract  similar documents
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva
"... supported by involvement of federal budget funds, to define the list of orphan drugs, to implement state ..."
 
Vol 10, No 2 (2017) COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD Abstract  similar documents
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov
"... wholesale premium). Other direct medical costs were calculated in accordance with the Federal program ..."
 
1 - 48 of 48 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)